Healthcare organizations are under pressure to cut costs by reducing the volume of inappropriate, unnecessary, redundant, or obsolete tests.
Integrating and Streamlining Testing
Testing Outside the Core Laboratory
Harmonization of Lab Test Results
Avoiding Inappropriate Testing
Atellica Process Manager2
The Siemens Healthineers Walpole Facility
Johnson AS. Point-of-care or clinical lab INR for anticoagulation monitoring: Which to believe? Clin Lab News. April 1, 2017. https://www.aacc.org/publications/cln/articles/2017/april/point-of-care-or-clinical-lab-inr-for-anticoagulation-monitoring-which-to-believe.
Hoerger TJ, Wittenborn JS, Young W. A cost-benefit analysis of lipid standardization in the United States. Prev Chronic Dis. 2011;8:A136.
Song Z, Safran DG, Landon BE, et al. Health care spending and quality in year 1 of the alternative quality contract. N Engl J Med. 2011;365:909-18.
Zhi M, Ding EL, Theisen-Toupal J, et al. The landscape of inappropriate laboratory testing: a 15-year meta-analysis. PLoS One. 2013;8:e78962.
Taylor JR, Thompson PJ, Genzen JR, et al. Opportunities to enhance laboratory professionals' role on the diagnostic team. Lab Med. 2017;48:97-103.
Ferraro S, Panteghini M. The role of laboratory in ensuring appropriate test requests. Clin Biochem. 2017;50:555-61.
DCA HbA1c test kit 10698915 (an aid to diagnose diabetes and identify patients at risk for developing diabetes) is not available for sale in the U.S. Product availability varies by country.
Product availability varies by country.
Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability.
The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.